|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 14-09-16 | CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals | RE |
| 14-09-04 | Roche : rules out mega deals, open to smaller ones - paper | RE |
Executive Committee: InterMune Inc
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Chief Tech/Sci/R&D Officer | 71 | 2002-03-31 | |
Carla Fiankan
LAW | General Counsel | - | 2011-07-31 |
Company details: InterMune Inc
Other Biotechnology & Medical Research
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.08% | +0.69% | -11.16% | -5.43% | 43.13B | |
| +1.52% | +3.78% | +314.86% | +565.24% | 34.65B | |
| -0.22% | +1.16% | +5.36% | +45.94% | 30.03B | |
| -2.19% | -7.96% | +5.81% | -23.14% | 28B | |
| -1.90% | -1.56% | +10.24% | +22.81% | 24.45B | |
| +0.28% | +3.95% | - | - | 14.34B | |
| -2.81% | -2.83% | +47.18% | +102.25% | 13.14B | |
| +0.38% | -1.17% | +5.24% | +7.44% | 12.53B | |
| +0.19% | +0.93% | +98.17% | +81.19% | 12.25B | |
| Average | -0.54% | +0.73% | +59.46% | +99.54% | 23.61B | |
| Weighted average by Cap. | -0.41% | +1.27% | +65.05% | +116.42% |
- Stock Market
- Stocks
- Stock
- Company InterMune Inc
Select your edition
All financial news and data tailored to specific country editions
